Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Non-Current Deferred Tax Liability (2023 - 2026)

Cartesian Therapeutics (RNAC) has disclosed Non-Current Deferred Tax Liability for 5 consecutive years, with $6.9 million as the latest value for Q1 2026.

  • For Q1 2026, Non-Current Deferred Tax Liability fell 56.95% year-over-year to $6.9 million; the TTM value through Mar 2026 reached $6.9 million, down 56.95%, while the annual FY2025 figure was $6.9 million, 56.95% down from the prior year.
  • Non-Current Deferred Tax Liability hit $6.9 million in Q1 2026 for Cartesian Therapeutics, roughly flat from $6.9 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $44.0 million in Q4 2023 and bottomed at $3.3 million in Q4 2022.
  • Average Non-Current Deferred Tax Liability over 5 years is $15.8 million, with a median of $15.9 million recorded in 2024.
  • Year-over-year, Non-Current Deferred Tax Liability soared 1252.47% in 2023 and then plummeted 63.34% in 2024.
  • Cartesian Therapeutics' Non-Current Deferred Tax Liability stood at $3.3 million in 2022, then skyrocketed by 1252.47% to $44.0 million in 2023, then tumbled by 63.34% to $16.1 million in 2024, then crashed by 56.95% to $6.9 million in 2025, then changed by 0.0% to $6.9 million in 2026.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $6.9 million, $6.9 million, and $16.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.